Shweta Puntambekar (@Mad4Microglia) header
Shweta Puntambekar (@Mad4Microglia) profile picture

Neuro-immunologist. Microglia enthusiast. Flow cytometry specialist. Food fanatic. Caffeine Addict. Animal lover. Bibliophile.

San Diego, California
Joined March 2022
Shweta Puntambekar retweeted
Good to see 👍
1
84
4
597
47,057
Shweta Puntambekar retweeted
"Although it seems clear that targeting amyloid β therapeutically makes sense, the question, who, when, & how to treat remains." A Therapeutics Review discusses the opportunities & challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease: hubs.li/Q02ZSC0p0
7
27
3
69
12,277
Shweta Puntambekar retweeted
Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia biorxiv.org/content/10.1101/…
28
1
151
14,246
Shweta Puntambekar retweeted
Lee et al. show in mice that microglia activated by Aβ drive neuroinflammation, which subsequently induces tau and α-synuclein aggregation and the associated neurodegenerative phenotypes. tinyurl.com/yytz39zs
14
49
5,042
Congratulations @domjacri !! The first one is always special! :)
Very excited to share that my first first-author paper with @jungsukim77 was published this morning in @JExpMed 😄 Thank you to all the lab members, collaborators, and everyone who made this possible!
1
7
473
A recent article by @ScienceMagazine highlights donanemab's effectiveness in slowing cognitive decline and associated risks. This milestone in advanced clinical trials for amyloid-targeting drugs offers hope for improved Alzheimer's treatments. science.org/content/article/…
2
9
1,003
It's exhausting to keep up with ❤-ing all the tweets from #AAIC2023 that mention .@Model_ad_alz, .@adrianoblak, .@LasagnaLab, .@btlamb, .@ApostolovaLiana or generally anything related to .@NeurosciStark! Congratations y'all!! #proudstarkie #goteamstark
17
547
Shweta Puntambekar retweeted
Results from TRAILBLAZER-ALZ 2, a phase 3 clinical study of an amyloid-targeting therapy (ATT) in development for people with early symptomatic Alzheimer's disease, were published in @JAMANetwork Click here to see the publication: e.lilly/42GdXqa
20
98
3
349
763,037
Liana Apostolova, MD, joined The Debrief on @scrippsnews to talk about the FDA's recent approval of Leqembi, a new drug to slow the effects of Alzheimer's disease. youtube.com/watch?v=FipURQZy…
4
9
2,562
🚨 New paper alert: Great to see it out today. It has been pleasure to be part of this study and this cool team. Congratulations to everyone 🎊
We are thrilled to share our most recent effort in modeling Alzheimer's disease using patient-derived iPSCs. We want to thank all the fantastic collaborators who have contributed to this work! ⁦@SpringerNature⁩ ⁦@molpsychiatry⁩ nature.com/articles/s41380-0…
1
2
6
597
All the good stuff about the role of microglial Abi3 in AD in one simple read! Congratulations @HandeKarahan_, @jungsukim77 and the whole team!! The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies frontiersin.org/articles/10.…
2
18
1,373